Literature DB >> 1579500

Alternatively spliced p53 RNA in transformed and normal cells of different tissue types.

K A Han1, M F Kulesz-Martin.   

Abstract

The alternatively spliced RNA species of tumor suppressor gene p53, containing an additional 96 bases derived from intron 10, is present at approximately 25 to 30% the level of regularly spliced p53 RNA in both normal epidermal and carcinoma cells. The presence of this alternatively spliced RNA in 10T1/2 fibroblast cells, mouse liver and testis suggests that this alternative splicing may be universal. The level of alternatively spliced p53 RNA was increased coordinately with that of regularly spliced p53 in 10T1/2 cells in response to epidermal growth factor. Immunoprecipitation analysis of epidermal cells using monoclonal antibodies which recognize different epitopes of p53 suggested that distinct p53 proteins may be translated from both RNA species. Considering previous observations on the potential importance of carboxyl terminal sequences in p53 function, knowledge of the ubiquitous presence of alternatively spliced p53 is important for future studies of p53 function in normal cells and in oncogenesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1579500      PMCID: PMC312315          DOI: 10.1093/nar/20.8.1979

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  17 in total

1.  Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation.

Authors:  J Milner; E A Medcalf
Journal:  Cell       Date:  1991-05-31       Impact factor: 41.582

2.  Tumor suppressor p53: analysis of wild-type and mutant p53 complexes.

Authors:  J Milner; E A Medcalf; A C Cook
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

Review 3.  Tumor suppressor genes: the p53 and retinoblastoma sensitivity genes and gene products.

Authors:  A J Levine; J Momand
Journal:  Biochim Biophys Acta       Date:  1990-06-01

4.  Protein-binding elements in the promoter region of the mouse p53 gene.

Authors:  D Ginsberg; M Oren; M Yaniv; J Piette
Journal:  Oncogene       Date:  1990-09       Impact factor: 9.867

5.  Addition of fresh medium induces cell cycle and conformation changes in p53, a tumour suppressor protein.

Authors:  J Milner; J V Watson
Journal:  Oncogene       Date:  1990-11       Impact factor: 9.867

6.  Altered levels of endogenous retrovirus-like sequence (VL30) RNA during mouse epidermal cell carcinogenesis.

Authors:  K A Han; P Rothberg; M Kulesz-Martin
Journal:  Mol Carcinog       Date:  1990       Impact factor: 4.784

7.  The tumor suppressor p53 is bound to RNA by a stable covalent linkage.

Authors:  A Samad; R B Carroll
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

8.  The p53 tumour suppressor protein is phosphorylated at serine 389 by casein kinase II.

Authors:  D W Meek; S Simon; U Kikkawa; W Eckhart
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

9.  Mouse cell clones for improved quantitation of carcinogen-induced altered differentiation.

Authors:  M Kulesz-Martin; M A Yoshida; L Prestine; S H Yuspa; J S Bertram
Journal:  Carcinogenesis       Date:  1985-09       Impact factor: 4.944

10.  Transforming growth factor alpha (TGF alpha) induction of C-FOS and C-MYC expression in C3H 10T1/2 cells.

Authors:  A F Cutry; A J Kinniburgh; D R Twardzik; C E Wenner
Journal:  Biochem Biophys Res Commun       Date:  1988-04-15       Impact factor: 3.575

View more
  17 in total

1.  Activities and response to DNA damage of latent and active sequence-specific DNA binding forms of mouse p53.

Authors:  Y Wu; H Huang; Z Miner; M Kulesz-Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

2.  Alternatively spliced forms in the carboxy-terminal domain of the p53 protein regulate its ability to promote annealing of complementary single strands of nucleic acids.

Authors:  L Wu; J H Bayle; B Elenbaas; N P Pavletich; A J Levine
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

3.  The murine C'-terminally alternatively spliced form of p53 induces attenuated apoptosis in myeloid cells.

Authors:  N Almog; R Li; A Peled; D Schwartz; R Wolkowicz; N Goldfinger; H Pei; V Rotter
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

4.  DNA binding specificity of proteins derived from alternatively spliced mouse p53 mRNAs.

Authors:  Z Miner; M Kulesz-Martin
Journal:  Nucleic Acids Res       Date:  1997-04-01       Impact factor: 16.971

5.  Species-specific regulation of alternative splicing in the C-terminal region of the p53 tumor suppressor gene.

Authors:  M Laverdière; J Beaudoin; A Lavigueur
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

6.  Augmented DNA-binding activity of p53 protein encoded by a carboxyl-terminal alternatively spliced mRNA is blocked by p53 protein encoded by the regularly spliced form.

Authors:  R Wolkowicz; A Peled; N B Elkind; V Rotter
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

7.  The carboxyl-terminal domain of the p53 protein regulates sequence-specific DNA binding through its nonspecific nucleic acid-binding activity.

Authors:  J H Bayle; B Elenbaas; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

8.  Endogenous p53 protein generated from wild-type alternatively spliced p53 RNA in mouse epidermal cells.

Authors:  M F Kulesz-Martin; B Lisafeld; H Huang; N D Kisiel; L Lee
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

9.  p53 Isoforms: An Intracellular Microprocessor?

Authors:  Marie P Khoury; Jean-Christophe Bourdon
Journal:  Genes Cancer       Date:  2011-04

10.  Species- and tissue-specific expression of the C-terminal alternatively spliced form of the tumor suppressor p53.

Authors:  K Will; G Warnecke; S Bergmann; W Deppert
Journal:  Nucleic Acids Res       Date:  1995-10-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.